| Sarah Lynn Bushnell, MSW | |
|
5469 Sw 34th St, Gainesville, FL 32608-5032 | |
| (352) 548-1900 | |
| Not Available |
| Full Name | Sarah Lynn Bushnell |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 5469 Sw 34th St, Gainesville, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003500299 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Lynn Bushnell, MSW 4229 Nw 43rd St Apt N105, Gainesville, FL 32606-2514 Ph: (352) 222-5526 | Sarah Lynn Bushnell, MSW 5469 Sw 34th St, Gainesville, FL 32608-5032 Ph: (352) 548-1900 |
News Archive
A collaboration of University of Pennsylvania and University of Wisconsin chemists and anesthesiologists have identified a fluorescent anesthetic compound that will assist researchers in obtaining more precise information about how anesthetics work in the body and will provide a means to more rapidly test new anesthetic compounds in the search for safer and more effective drugs.
On the heels of the release of a draft report by an independent panel of experts examining the WHO's response to H1N1, BMJ News reports on a recently approved resolution and accompanying report released by the European Union parliament that calls on EU countries to revise their flu prevention plans "to make them more effective, coherent, and flexible" and for the WHO to revise its definition of pandemic to take into account not only geographical spread of disease but also severity.
An article published in the January issue of the International Journal of Radiation Oncology, Biology and Physics reports results of the Radiation Therapy Oncology Group (RTOG) phase II clinical trial of Bevacizumab (Avastin) in addition to cisplatin and pelvic radiation for locally advanced cervical cancer.
PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, today announced that the Company has received 510K clearance from the U.S. Food and Drug Administration for its GSP™ Genetic Screening Processor, which is used by public health laboratories worldwide as part of newborn screening programs.
Leading scientists have selected the first drugs to be evaluated in a worldwide clinical study to determine whether they can prevent Alzheimer's disease.
› Verified 2 days ago
Mrs. Joanne Block, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4131 Nw 28th Ln, Suite 6, Gainesville, FL 32606 Phone: 352-375-3001 Fax: 352-375-1003 | |
Ms. Cathy Jeanne Price, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1601 Sw Archer Rd, Gainesville, FL 32608 Phone: 352-376-1611 | |
Charnette Merritt, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4300 Sw 13th St, Gainesville, FL 32608 Phone: 352-374-5600 Fax: 352-374-5608 | |
Jakira L Harris, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1601 Sw Archer Rd, Gainesville, FL 32608 Phone: 352-376-1611 | |
Amanda Cruce, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3031 Nw 161st Ct, Gainesville, FL 32609 Phone: 352-214-6300 | |
Daimian Holiday Scott, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1315 Ne 7th Ter, Gainesville, FL 32601 Phone: 352-448-1052 |